Apelin-13 inhibits lipoprotein lipase expression via the APJ/PKCα/miR-361-5p signaling pathway in THP-1 macrophage-derived foam cells
Authors:
- 21 April 2017
- journal article
- research article
- Published by China Science Publishing & Media Ltd. in Acta Biochimica et Biophysica Sinica
- Vol. 49 (6) , 530-540
Abstract
Atherosclerotic lesions are characterized by the accumulation of abundant lipids and chronic inflammation. Previous researches have indicated that macrophage-derived lipoprotein lipase (LPL) promotes atherosclerosis progression by accelerating lipid accumulation and pro-inflammatory cytokine secretion. Although apelin-13 has been regarded as an atheroprotective factor, it remains unclear whether it can regulate the expression of LPL. The aim of this study was to explore the effects of apelin-13 on the expression of LPL and the underlying mechanism in THP-1 macrophage-derived foam cells. Apelin-13 significantly decreased cellular levels of total cholesterol, free cholesterol, and cholesterol ester at the concentrations of 10 and 100 nM. ELISA analysis confirmed that treatment with apelin-13 reduced pro-inflammatory cytokine secretion, such as interleukin-6 (IL-6), interleukin-1β (IL-1β) and tumor necrosis factor-alpha (TNF-α). It was also found that apelin-13 inhibited the expression of LPL as revealed by western blot and real-time PCR analyses. Bioinformatics analyses and dual-luciferase reporter assay indicated that miR-361-5p directly downregulated the expression of LPL by targeting the 3′UTR of LPL. In addition, apelin-13 + miR-361-5p mimic significantly downregulated the expression of LPL in cells. Finally, we demonstrated that apelin-13 downregulated the expression of LPL through activating the activity of PKCα. Taken together, our results showed that apelin-13 downregulated the expression of LPL via activating the APJ/PKCα/miR-361-5p signaling pathway in THP-1 macrophage-derived foam cells, leading to inhibition of lipid accumulation and pro-inflammatory cytokine secretion. Therefore, our studies provide important new insight into the inhibition of lipid accumulation and pro-inflammatory cytokine secretion by apelin-13, and highlight apelin-13 as a promising therapeutic target in atherosclerosis.Keywords
This publication has 31 references indexed in Scilit:
- The effects of miR-467b on lipoprotein lipase (LPL) expression, pro-inflammatory cytokine, lipid levels and atherosclerotic lesions in apolipoprotein E knockout miceBiochemical and Biophysical Research Communications, 2014
- Circulating microRNAs levels in Chinese heart failure patients caused by dilated cardiomyopathyIndian Heart Journal, 2013
- The Expression Levels of MicroRNA-361-5p and Its Target VEGFA Are Inversely Correlated in Human Cutaneous Squamous Cell CarcinomaPLOS ONE, 2012
- Apelin-13 increases myocardial progenitor cells and improves repair postmyocardial infarctionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2012
- Non-activated APJ suppresses the angiotensin II type 1 receptor, whereas apelin-activated APJ acts converselyHypertension Research, 2011
- Modulation of the apelin/APJ system in heart failure and atherosclerosis in manBritish Journal of Pharmacology, 2010
- Requirement of Apelin-Apelin Receptor System for Oxidative Stress-Linked AtherosclerosisThe American Journal of Pathology, 2007
- Therapeutic potential of interfering with apelin signallingDrug Discovery Today, 2006
- Down-regulation of cardiac apelin system in hypertrophied and failing hearts: Possible role of angiotensin II–angiotensin type 1 receptor systemJournal of Molecular and Cellular Cardiology, 2006
- Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivoJournal of Clinical Investigation, 1999